From the prospectus. 13.2 The Company is developing prototypes...

From the prospectus.

1. 13.2 The Company is developing prototypes of other tissue expansion products and intends in the future to offer
   a range of additional products that can utilise the Company’s CO2 concept for tissue expansion in other applications such as for burn, paediatric and trauma patients. However, the Company cannot guarantee that it will in fact offer additional products in the future. If the Company does offer additional products, any devices developed by the Company for these applications will have to go through the FDA clearance process.
   Tissue expanders for paediatric burns is a particular area of potential opportunity. Today, over 15,000 burn cases present in the US alone. In markets outside of the US, particularly in less developed countries, the incidence is much higher. Many of these burns currently require tissue expansion via saline expanders for treatment. The prospect of sticking a needle in a device placed under the skin of a burns patient can be horrifying, particularly to a child. By employing the Company’s needle free technology, the process of tissue expansion has the potential to be greatly simplified and improved for potentially many applications. Other possible applications include:
   • > round, rectangular or crescent shaped expanders to address congenital deformities such as nevi or where additional skin is needed to cover a defect; and
   • > non-breast shaped devices to aid in expanding tissue and skin surface area for other reconstructive purposes.
     The Company has applied for further patents to include uses of its core technology for many applications throughout the body.